Point72 Hong Kong LTD Medpace Holdings, Inc. Transaction History

Point72 Hong Kong LTD

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$372.0 - $424.34 $713,124 - $813,459	-1,917 Reduced 73.65%	686 $282,000
Q1 2024 May 15, 2024	BUY	$284.87 - $413.31 $370,046 - $536,889	1,299 Added 99.62%	2,603 $1.05 Million
Q4 2023 Feb 14, 2024	BUY	$227.52 - $312.68 $296,686 - $407,734	1,304 New	1,304 $399,000
Q3 2022 Nov 14, 2022	BUY	$145.13 - $182.49 $89,400 - $112,413	616 Added 218.44%	898 $141,000
Q2 2022 Aug 15, 2022	BUY	$130.2 - $168.03 $36,716 - $47,384	282 New	282 $42,000
Q3 2021 Nov 15, 2021	SELL	$170.18 - $198.21 $75,900 - $88,401	-446 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$158.62 - $194.3 $28,710 - $35,168	181 Added 68.3%	446 $79,000
Q1 2021 May 17, 2021	BUY	$132.02 - $168.26 $34,985 - $44,588	265 New	265 $43,000
Q1 2020 May 15, 2020	SELL	$61.71 - $101.95 $8,084 - $13,355	-131 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$70.08 - $84.64 $9,180 - $11,087	131 New	131 $11,000
Q2 2019 Aug 14, 2019	SELL	$53.64 - $65.42 $1,126 - $1,373	-21 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$49.38 - $70.58 $1,036 - $1,482	21 New	21 $1,000
Q3 2018 Nov 14, 2018	SELL	$43.25 - $63.74 $13,407 - $19,759	-310 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$34.03 - $45.46 $10,549 - $14,092	310 New	310 $13,000

617

25.1M

42.8K

207K

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $10.3B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.